Watching the market: Yingli Automobile and other 5 stocks stopped in seconds CFi.CN Zhongcai Network Post date May 17, 2022 — 10:28 Post Lock Read More Jingfeng Medicine: Jingfeng has nothing to do with Zhejiang Arthur Medicine Post date May 9, 2022 — 21:00 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D Post date May 8, 2022 — 20:56 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): Subsidiary Pregabalin Capsules Approved for Listing_Individual Stock Information_Market Gold Online Post date April 22, 2022 — 20:47 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): Subsidiary Pregabalin Capsules Approved for Listing- Post date April 22, 2022 — 20:25 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908): Announcement on the Progress of Share Transfer by Shareholder Agreement- CFi.CN Zhongcai Network Post date April 20, 2022 — 07:46 Post Lock Read More China Biotech's two new coronavirus Omicron inactivated vaccines received clinical approval from Hong Kong Junshi Bio's new crown oral drug VV116 released the latest research results Post date April 18, 2022 — 18:46 Post Lock Read More Investors——Experience the compound interest of knowledge ❤️ 1. Investor endowments: require three extremes, extreme patience, extreme determination, and extreme interest in business and commodities. 2. Investment varieties: can only be concentrated, and must be concentrated. One… Snowball Post date April 4, 2022 — 22:18 Post Lock Read More Jingfeng Pharmaceutical's controlling shareholder Zhouyu Energy pledged 33 million shares for its own business development_TOM Technology Post date April 3, 2022 — 19:24 Post Lock Read More
Jingfeng Medicine: Jingfeng has nothing to do with Zhejiang Arthur Medicine Post date May 9, 2022 — 21:00 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D Post date May 8, 2022 — 20:56 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): Subsidiary Pregabalin Capsules Approved for Listing_Individual Stock Information_Market Gold Online Post date April 22, 2022 — 20:47 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): Subsidiary Pregabalin Capsules Approved for Listing- Post date April 22, 2022 — 20:25 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908): Announcement on the Progress of Share Transfer by Shareholder Agreement- CFi.CN Zhongcai Network Post date April 20, 2022 — 07:46 Post Lock Read More China Biotech's two new coronavirus Omicron inactivated vaccines received clinical approval from Hong Kong Junshi Bio's new crown oral drug VV116 released the latest research results Post date April 18, 2022 — 18:46 Post Lock Read More Investors——Experience the compound interest of knowledge ❤️ 1. Investor endowments: require three extremes, extreme patience, extreme determination, and extreme interest in business and commodities. 2. Investment varieties: can only be concentrated, and must be concentrated. One… Snowball Post date April 4, 2022 — 22:18 Post Lock Read More Jingfeng Pharmaceutical's controlling shareholder Zhouyu Energy pledged 33 million shares for its own business development_TOM Technology Post date April 3, 2022 — 19:24 Post Lock Read More
R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D Post date May 8, 2022 — 20:56 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): Subsidiary Pregabalin Capsules Approved for Listing_Individual Stock Information_Market Gold Online Post date April 22, 2022 — 20:47 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): Subsidiary Pregabalin Capsules Approved for Listing- Post date April 22, 2022 — 20:25 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908): Announcement on the Progress of Share Transfer by Shareholder Agreement- CFi.CN Zhongcai Network Post date April 20, 2022 — 07:46 Post Lock Read More China Biotech's two new coronavirus Omicron inactivated vaccines received clinical approval from Hong Kong Junshi Bio's new crown oral drug VV116 released the latest research results Post date April 18, 2022 — 18:46 Post Lock Read More Investors——Experience the compound interest of knowledge ❤️ 1. Investor endowments: require three extremes, extreme patience, extreme determination, and extreme interest in business and commodities. 2. Investment varieties: can only be concentrated, and must be concentrated. One… Snowball Post date April 4, 2022 — 22:18 Post Lock Read More Jingfeng Pharmaceutical's controlling shareholder Zhouyu Energy pledged 33 million shares for its own business development_TOM Technology Post date April 3, 2022 — 19:24 Post Lock Read More
A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D Post date May 8, 2022 — 20:56 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): Subsidiary Pregabalin Capsules Approved for Listing_Individual Stock Information_Market Gold Online Post date April 22, 2022 — 20:47 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): Subsidiary Pregabalin Capsules Approved for Listing- Post date April 22, 2022 — 20:25 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908): Announcement on the Progress of Share Transfer by Shareholder Agreement- CFi.CN Zhongcai Network Post date April 20, 2022 — 07:46 Post Lock Read More China Biotech's two new coronavirus Omicron inactivated vaccines received clinical approval from Hong Kong Junshi Bio's new crown oral drug VV116 released the latest research results Post date April 18, 2022 — 18:46 Post Lock Read More Investors——Experience the compound interest of knowledge ❤️ 1. Investor endowments: require three extremes, extreme patience, extreme determination, and extreme interest in business and commodities. 2. Investment varieties: can only be concentrated, and must be concentrated. One… Snowball Post date April 4, 2022 — 22:18 Post Lock Read More Jingfeng Pharmaceutical's controlling shareholder Zhouyu Energy pledged 33 million shares for its own business development_TOM Technology Post date April 3, 2022 — 19:24 Post Lock Read More
A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D Post date May 8, 2022 — 20:56 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): Subsidiary Pregabalin Capsules Approved for Listing_Individual Stock Information_Market Gold Online Post date April 22, 2022 — 20:47 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): Subsidiary Pregabalin Capsules Approved for Listing- Post date April 22, 2022 — 20:25 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908): Announcement on the Progress of Share Transfer by Shareholder Agreement- CFi.CN Zhongcai Network Post date April 20, 2022 — 07:46 Post Lock Read More China Biotech's two new coronavirus Omicron inactivated vaccines received clinical approval from Hong Kong Junshi Bio's new crown oral drug VV116 released the latest research results Post date April 18, 2022 — 18:46 Post Lock Read More Investors——Experience the compound interest of knowledge ❤️ 1. Investor endowments: require three extremes, extreme patience, extreme determination, and extreme interest in business and commodities. 2. Investment varieties: can only be concentrated, and must be concentrated. One… Snowball Post date April 4, 2022 — 22:18 Post Lock Read More Jingfeng Pharmaceutical's controlling shareholder Zhouyu Energy pledged 33 million shares for its own business development_TOM Technology Post date April 3, 2022 — 19:24 Post Lock Read More
Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): Subsidiary Pregabalin Capsules Approved for Listing_Individual Stock Information_Market Gold Online Post date April 22, 2022 — 20:47 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): Subsidiary Pregabalin Capsules Approved for Listing- Post date April 22, 2022 — 20:25 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908): Announcement on the Progress of Share Transfer by Shareholder Agreement- CFi.CN Zhongcai Network Post date April 20, 2022 — 07:46 Post Lock Read More China Biotech's two new coronavirus Omicron inactivated vaccines received clinical approval from Hong Kong Junshi Bio's new crown oral drug VV116 released the latest research results Post date April 18, 2022 — 18:46 Post Lock Read More Investors——Experience the compound interest of knowledge ❤️ 1. Investor endowments: require three extremes, extreme patience, extreme determination, and extreme interest in business and commodities. 2. Investment varieties: can only be concentrated, and must be concentrated. One… Snowball Post date April 4, 2022 — 22:18 Post Lock Read More Jingfeng Pharmaceutical's controlling shareholder Zhouyu Energy pledged 33 million shares for its own business development_TOM Technology Post date April 3, 2022 — 19:24 Post Lock Read More
Jingfeng Pharmaceutical (000908.SZ): Subsidiary Pregabalin Capsules Approved for Listing_Individual Stock Information_Market Gold Online Post date April 22, 2022 — 20:47 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): Subsidiary Pregabalin Capsules Approved for Listing- Post date April 22, 2022 — 20:25 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908): Announcement on the Progress of Share Transfer by Shareholder Agreement- CFi.CN Zhongcai Network Post date April 20, 2022 — 07:46 Post Lock Read More China Biotech's two new coronavirus Omicron inactivated vaccines received clinical approval from Hong Kong Junshi Bio's new crown oral drug VV116 released the latest research results Post date April 18, 2022 — 18:46 Post Lock Read More Investors——Experience the compound interest of knowledge ❤️ 1. Investor endowments: require three extremes, extreme patience, extreme determination, and extreme interest in business and commodities. 2. Investment varieties: can only be concentrated, and must be concentrated. One… Snowball Post date April 4, 2022 — 22:18 Post Lock Read More Jingfeng Pharmaceutical's controlling shareholder Zhouyu Energy pledged 33 million shares for its own business development_TOM Technology Post date April 3, 2022 — 19:24 Post Lock Read More
Jingfeng Pharmaceutical (000908.SZ): Subsidiary Pregabalin Capsules Approved for Listing- Post date April 22, 2022 — 20:25 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908): Announcement on the Progress of Share Transfer by Shareholder Agreement- CFi.CN Zhongcai Network Post date April 20, 2022 — 07:46 Post Lock Read More China Biotech's two new coronavirus Omicron inactivated vaccines received clinical approval from Hong Kong Junshi Bio's new crown oral drug VV116 released the latest research results Post date April 18, 2022 — 18:46 Post Lock Read More Investors——Experience the compound interest of knowledge ❤️ 1. Investor endowments: require three extremes, extreme patience, extreme determination, and extreme interest in business and commodities. 2. Investment varieties: can only be concentrated, and must be concentrated. One… Snowball Post date April 4, 2022 — 22:18 Post Lock Read More Jingfeng Pharmaceutical's controlling shareholder Zhouyu Energy pledged 33 million shares for its own business development_TOM Technology Post date April 3, 2022 — 19:24 Post Lock Read More
Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908): Announcement on the Progress of Share Transfer by Shareholder Agreement- CFi.CN Zhongcai Network Post date April 20, 2022 — 07:46 Post Lock Read More China Biotech's two new coronavirus Omicron inactivated vaccines received clinical approval from Hong Kong Junshi Bio's new crown oral drug VV116 released the latest research results Post date April 18, 2022 — 18:46 Post Lock Read More Investors——Experience the compound interest of knowledge ❤️ 1. Investor endowments: require three extremes, extreme patience, extreme determination, and extreme interest in business and commodities. 2. Investment varieties: can only be concentrated, and must be concentrated. One… Snowball Post date April 4, 2022 — 22:18 Post Lock Read More Jingfeng Pharmaceutical's controlling shareholder Zhouyu Energy pledged 33 million shares for its own business development_TOM Technology Post date April 3, 2022 — 19:24 Post Lock Read More
Jingfeng Pharmaceutical (000908.SZ): "Pregabalin Capsules" Approved for Registration Post date April 22, 2022 — 20:18 Post Lock Read More Jingfeng Pharmaceutical (000908): Announcement on the Progress of Share Transfer by Shareholder Agreement- CFi.CN Zhongcai Network Post date April 20, 2022 — 07:46 Post Lock Read More China Biotech's two new coronavirus Omicron inactivated vaccines received clinical approval from Hong Kong Junshi Bio's new crown oral drug VV116 released the latest research results Post date April 18, 2022 — 18:46 Post Lock Read More Investors——Experience the compound interest of knowledge ❤️ 1. Investor endowments: require three extremes, extreme patience, extreme determination, and extreme interest in business and commodities. 2. Investment varieties: can only be concentrated, and must be concentrated. One… Snowball Post date April 4, 2022 — 22:18 Post Lock Read More Jingfeng Pharmaceutical's controlling shareholder Zhouyu Energy pledged 33 million shares for its own business development_TOM Technology Post date April 3, 2022 — 19:24 Post Lock Read More
Jingfeng Pharmaceutical (000908): Announcement on the Progress of Share Transfer by Shareholder Agreement- CFi.CN Zhongcai Network Post date April 20, 2022 — 07:46 Post Lock Read More China Biotech's two new coronavirus Omicron inactivated vaccines received clinical approval from Hong Kong Junshi Bio's new crown oral drug VV116 released the latest research results Post date April 18, 2022 — 18:46 Post Lock Read More Investors——Experience the compound interest of knowledge ❤️ 1. Investor endowments: require three extremes, extreme patience, extreme determination, and extreme interest in business and commodities. 2. Investment varieties: can only be concentrated, and must be concentrated. One… Snowball Post date April 4, 2022 — 22:18 Post Lock Read More Jingfeng Pharmaceutical's controlling shareholder Zhouyu Energy pledged 33 million shares for its own business development_TOM Technology Post date April 3, 2022 — 19:24 Post Lock Read More
China Biotech's two new coronavirus Omicron inactivated vaccines received clinical approval from Hong Kong Junshi Bio's new crown oral drug VV116 released the latest research results Post date April 18, 2022 — 18:46 Post Lock Read More Investors——Experience the compound interest of knowledge ❤️ 1. Investor endowments: require three extremes, extreme patience, extreme determination, and extreme interest in business and commodities. 2. Investment varieties: can only be concentrated, and must be concentrated. One… Snowball Post date April 4, 2022 — 22:18 Post Lock Read More Jingfeng Pharmaceutical's controlling shareholder Zhouyu Energy pledged 33 million shares for its own business development_TOM Technology Post date April 3, 2022 — 19:24 Post Lock Read More
Investors——Experience the compound interest of knowledge ❤️ 1. Investor endowments: require three extremes, extreme patience, extreme determination, and extreme interest in business and commodities. 2. Investment varieties: can only be concentrated, and must be concentrated. One… Snowball Post date April 4, 2022 — 22:18 Post Lock Read More Jingfeng Pharmaceutical's controlling shareholder Zhouyu Energy pledged 33 million shares for its own business development_TOM Technology Post date April 3, 2022 — 19:24 Post Lock Read More
Jingfeng Pharmaceutical's controlling shareholder Zhouyu Energy pledged 33 million shares for its own business development_TOM Technology Post date April 3, 2022 — 19:24 Post Lock Read More
Caishen.CoCaishen.Co